Brimonidine Tartrate
Overview
Brimonidine Tartrate is an alpha-2 adrenergic receptor agonist primarily used to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It works by decreasing the production of aqueous humor and increasing uveoscleral outflow.
API suppliers (8)
Suppliers of Brimonidine Tartrate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 6 of 8 suppliers.
5 of 8 hold a GMP certificate on record in the EU or UK registers
- MEDICHEM SASpain1 active DMF GMP on record
- Viyash Scientific LtdIndia1 active DMF GMP on record
- C-SQUARED PHARMA LTDUnited States1 active DMF
- SIEGFRIED GRAFTON INC1 active DMF
- Unichem Laboratories Ltd.India1 active DMF GMP on record
- Piramal Pharma LimitedIndia1 active DMF GMP on record
- CZECH-GEN A.S.1 active DMF
- Lupin LimitedIndia GMP on record
Therapeutic areas
Do you supply Brimonidine Tartrate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.